Filed 2mo ago· Apr 3, 2026
10 days to disclose
Kevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMar 24, 2026
Common Stock
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–18 of 18
Filed 1.4y ago· Jan 15, 2025
15 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Johnson & Johnson
JNJ
$100K-$250K
+8.0% vs S&P 500
Trade dateDec 31, 2024
⚑ Pharmaceutical
Filed 1.9y ago· Jul 15, 2024
41 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+18.8% vs S&P 500
Trade dateJun 4, 2024
⚑ Pharmaceutical
Filed 2.1y ago· Apr 12, 2024
38 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+1.4% vs S&P 500
Trade dateMar 5, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 11, 2024
40 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateJan 2, 2024
Common Stock
⚑ Pharmaceutical
Filed 2.6y ago· Oct 13, 2023
24 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−21.0% vs S&P 500
Trade dateSep 19, 2023
⚑ Pharmaceutical
Filed 2.9y ago· Jul 12, 2023
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−24.8% vs S&P 500
Trade dateJun 16, 2023
⚑ Pharmaceutical
Filed 3.2y ago· Apr 10, 2023
13 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−30.6% vs S&P 500
Trade dateMar 28, 2023
⚑ Pharmaceutical
Filed 3.3y ago· Feb 14, 2023
14 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateJan 31, 2023
⚑ Pharmaceutical
Filed 3.3y ago· Feb 14, 2023
14 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+36.4% vs S&P 500
Trade dateJan 31, 2023
⚑ Pharmaceutical
Filed 3.3y ago· Feb 14, 2023
14 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Novartis Ag
NVS
$1K-$15K
+15.1% vs S&P 500
Trade dateJan 31, 2023
⚑ Pharmaceutical
Filed 3.4y ago· Jan 13, 2023
25 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$50K-$100K
Trade dateDec 19, 2022
⚑ Pharmaceutical
Filed 4.0y ago· Jun 14, 2022
29 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 16, 2022
⚑ Pharmaceutical
Filed 4.7y ago· Oct 7, 2021
30 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+30.4% vs S&P 500
Trade dateSep 7, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 20, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 20, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$1K-$15K
Trade dateMay 20, 2021
⚑ Pharmaceutical
Filed 5.0y ago· Jun 15, 2021
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Exact Sciences
EXAS
$50K-$100K
Trade dateMay 20, 2021
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 3, 2026 2mo ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS Common Stock ⚑ Pharmaceutical · Ways and Means | Mar 24, 2026 10 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 15, 2025 1.4y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 31, 2024 15 days to disclose | Flat·+0.0% +8.0% vs S&P 500 | $100K-$250K midpoint $175K |
Jul 15, 2024 1.9y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 4, 2024 41 days to disclose | Good buy·+$4.3K+53.9% +18.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 12, 2024 2.1y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 5, 2024 38 days to disclose | Good buy·+$3.4K+42.2% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2024 2.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS Common Stock ⚑ Pharmaceutical · Ways and Means | Jan 2, 2024 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Oct 13, 2023 2.6y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 19, 2023 24 days to disclose | Good buy·+$3.2K+40.3% −21.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 12, 2023 2.9y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 16, 2023 26 days to disclose | Good buy·+$3.1K+38.5% −24.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2023 3.2y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 28, 2023 13 days to disclose | Good buy·+$4K+49.8% −30.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | Jan 31, 2023 14 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 31, 2023 14 days to disclose | Missed gain·−$3.1K-39.2% +36.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Novartis Ag NVS ⚑ Pharmaceutical · Ways and Means | Jan 31, 2023 14 days to disclose | Missed gain·−$4.8K-60.5% +15.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2023 3.4y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | Dec 19, 2022 25 days to disclose | price pending | $50K-$100K midpoint $75K |
Jun 14, 2022 4.0y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 16, 2022 29 days to disclose | price pending | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 7, 2021 30 days to disclose | Good buy·+$3.2K+39.5% +30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Exact Sciences EXAS ⚑ Pharmaceutical · Ways and Means | May 20, 2021 26 days to disclose | price pending | $50K-$100K midpoint $75K |